Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
15.08. | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
14.08. | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
14.08. | Glucotrack, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
14.08. | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 135 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
06.08. | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com | ||
06.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
06.08. | Glucotrack, Inc.: Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology | 130 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people... ► Artikel lesen | |
31.07. | Glucotrack, Inc.: Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting | 1 | GlobeNewswire (USA) | ||
GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
24.07. | Glucotrack, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
08.07. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
08.07. | Glucotrack, Inc.: Glucotrack Announces Repurchase of Series A Warrants | 1 | GlobeNewswire (USA) | ||
27.06. | Pre-market Movers: Blue Gold, INmune Bio, Cyngn, NanoVibronix, GlucoTrack | 806 | AFX News | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.20 A.M. ET).In the Green Blue Gold Limited (BGL) is up over 297% at $80.01.
INmune... ► Artikel lesen | |
25.06. | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | 2 | RTTNews | ||
25.06. | Why Is This Nano-Cap Glucotrack Stock Trading Higher On Wednesday? | 3 | Benzinga.com | ||
25.06. | Glucotrack reports positive results from first human trial of blood glucose monitor | 3 | Investing.com | ||
25.06. | Glucotrack berichtet über positive Ergebnisse der ersten klinischen Studie am Menschen | 2 | Investing.com Deutsch | ||
25.06. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.06. | A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology | 1 | MassDevice | ||
12.06. | Glucotrack announces 1-for-60 reverse stock split effective June 16 | 2 | Investing.com | ||
12.06. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 17,480 | +0,46 % | Eckert & Ziegler, Hugo Boss, Northern Data, Puma, Renk, TUI - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
SERNOVA BIOTHERAPEUTICS | 0,116 | +1,75 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
SYNLAB | 12,710 | 0,00 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
NUGEN MEDICAL DEVICES | 0,035 | +2,37 % | Massive News: Volumen- und Kursexplosion durch "InsuJet 2.0"?! | ||
ATOSSA THERAPEUTICS | 0,675 | +1,81 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
PING AN HEALTHCARE | 2,005 | -0,74 % | Ping An Healthcare and Technology Company Limited: Ping An Good Doctor (1833.HK) Reports Solid Interim Results with Steady Revenue and Profit Growth | HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update | -- Increased Net Sales and Improved Loss from Operations in Q2 2025 vs. Prior Year Quarter --
-- Evofem Advances Plans for Special Meeting of Stockholders to Approve... ► Artikel lesen | |
UNIDOC HEALTH | 0,137 | -100,00 % | CSE Bulletin: Suspensions - Justera Health Ltd., Toggle3D.ai Inc., JIVA Technologies Inc., UniDoc Health Corp. | Toronto, Ontario--(Newsfile Corp. - Le 6 août/August 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Pre-market Movers: Sonoma Pharmaceuticals, Bolt Projects, Ibotta, TeraWulf, 180 Life Sciences | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.50 A.M. ET).In the Green Sonoma Pharmaceuticals, Inc. (SNOA) is up over... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,011 | -13,64 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
CO-DIAGNOSTICS | 0,244 | +9,91 % | Co-Diagnostics stock rating reiterated as Neutral by H.C. Wainwright | ||
CYTOSORBENTS | 0,791 | +1,15 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
VERU | 3,610 | +1,69 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
QUIDELORTHO | 23,600 | -1,67 % | QuidelOrtho Corporation: QuidelOrtho Completes Debt Refinancing | SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic... ► Artikel lesen | |
EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] |